Navigate
X
    QualityStocks
  • 18 years ago

VioQuest Pharmaceuticals, Inc. (OTC BB: VOQP)

VioQuest Pharmaceuticals, Inc. (OTC BB: VOQP) , a New Jersey-based biotechnology company, is focused on becoming a leader in the successful development of novel drug therapies designed to target both the molecular basis of cancer and side effects of treatment. The company’s oncology portfolio currently includes: Xyfid™, for the treatment of dry skin conditions and to manage the burning and itching associated with various dermatoses; VQD-002, a targeted inhibitor of Akt activation; and Lenocta™, an inhibitor of certain protein tyrosine phosphatases. For further information, visit the Company’s web site at www.vioquestpharm.com.

Tags Rodman & Renshaw
Related Post
  1. Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

    In the United States alone, close to one million people are living with MS, with…

  2. Why Verbal Skills Aren’t Enough: WRAP’s New Doctrine Aims to Give Officers a Lawful Next Step

    California's SB 230 requires agencies to incorporate de-escalation and alternatives to force into their use-of-force…

  3. Beeline Holdings Inc. (NASDAQ: BLNE) Partners with Loft 100 Studios to Examine the Mortgage Market and New Approaches to Homeownership

    The partnership will focus on the production of a 45-minute “Bizumentary” examining current challenges and…